Citigroup’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $589K | Buy |
|
|||||
|
2023
Q2 | $2.39K | Buy |
|
|||||
|
2023
Q1 | $3.16K | Sell |
|
|||||
|
2022
Q4 | $4.56K | Sell |
|
|||||
|
2022
Q3 | $11K | Sell |
|
|||||
|
2022
Q2 | $35K | Sell |
|
|||||
|
2022
Q1 | $55K | Sell |
|
|||||
|
2021
Q4 | $156K | Buy |
|
|||||
|
2021
Q3 | $87K | Buy |
|
|||||
|
2021
Q2 | $33K | Buy |
|
|||||
|
2021
Q1 | $31K | Sell |
|
|||||
|
2020
Q4 | $607K | Buy |
|